Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.
about
Circulating tumor cells: approaches to isolation and characterizationMinimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsMetastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?Minimal residual disease and circulating tumor cells in breast cancerCirculating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionDissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the HaystackPotential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current EvidenceCirculating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical studyNanotheranostics of circulating tumor cells, infections and other pathological features in vivoGenetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.Towards Engineered Processes for Sequencing-Based Analysis of Single Circulating Tumor CellsCurrent status of mucins in the diagnosis and therapy of cancer.Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Circulating tumor cells in non-metastatic triple-negative breast cancer.Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transitionCirculating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progressionThe Evolving Role of Circulating Tumor Cells in the Personalized Management of Breast Cancer: from Enumeration to Molecular Characterization.CTC enumeration and characterization: moving toward personalized medicine.Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker.Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood.Correlation between Cancer Stem Cells and Circulating Tumor Cells and Their ValueHeterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patientsApplication of circulating tumor cells scope technique on circulating tumor cell researchHighly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients.Fourier ptychographic microscopy for filtration-based circulating tumor cell enumeration and analysis.Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsEpithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCRComparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer.Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCRComparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.
P2860
Q24631347-70A45357-4112-4A2E-9867-63760FC3D0FEQ26748850-BB719B5A-B5EC-4EE4-A0CE-5AD751A57810Q26796595-CF6D4F94-E9DE-42AD-A240-FE7D6DAF8F0AQ27010152-E483D8F2-A4B7-4ECF-A36D-CE8A587A0FC9Q28066285-A471DB8C-358E-4FB4-85D5-F809F4248708Q28067549-B835ACDF-1696-4752-AC4D-2DB2C5A9C218Q28075850-856715E4-487B-464A-8B81-BCEBFDCAA76AQ28535476-9CEB8BC5-501F-4C0C-8162-5CEE8ED7893DQ30442087-7ECD0A16-DA55-4319-BF57-DDF0CC116C65Q33350614-EA0907FD-49C0-4FC4-A831-703F6FFBC1B2Q33604017-2F820064-ED2B-4287-85D8-3AF9D48C7779Q33757326-B851D977-7E09-4690-BE49-FB018DBB5E58Q33820233-8C329D9B-88B9-4B7C-B9D1-381FEF2C6DF3Q34111867-2B11B3CA-6CFB-4B29-BA01-0EFF6D539C6BQ34271512-A96671DA-C3E4-495E-B249-57BADE5573C4Q34496964-2BF616D4-CF3E-41AE-846E-F598D4629726Q34564188-73204156-4773-4659-824E-FB58B6F71BB5Q34577724-7865A42F-17DD-4BB6-9B82-2618F4E0D764Q34687153-0B316A0E-F4AC-4DF6-9C99-FAFFC50F68A9Q34799198-5FB28D0C-5EA6-438B-B257-9151F7A7E764Q34859215-0E93BA7D-8AA6-4B4E-BA76-CD3DBE72F174Q34994963-0BE16BC2-39E1-48F8-BBDC-23C75E740559Q35673870-F793188A-7849-48A3-B0BF-3A571E3AC4B1Q35735913-F5FEB15F-6A1D-48FA-9A19-C1EDDAC7A1FCQ36065551-1443AEEB-A47B-4EDE-A94C-DD4E69C0773FQ36072794-391D76C5-AED6-4729-B9CF-8E1D8E47D3D8Q36393149-CB20ABF3-602B-4532-8E4D-6778456FA702Q36406697-E1F0D659-516A-4255-B385-D0C5D5241E72Q36525788-FCBADEF8-DCEC-4A28-B98A-8E9BE0027D67Q36774761-FCC969EB-DE02-42D0-BBCD-F97E7005AB9AQ36902974-06C229C2-2590-4160-AAB6-E5E4AD09C5B3Q36924426-3E850A3F-65F1-42EC-BDBC-6593C4518FC8Q36959162-3E07C174-DAE0-4942-881F-E4C16BB339BDQ37352090-2AC313FE-22F8-4349-BB50-489B7641A404Q37360176-5D42EAC5-2414-417A-9FCD-3D93C5E0076EQ37360230-38BC423F-D7C9-440E-AC82-FB53C64C60CAQ37386179-F5B09959-089C-4271-B568-62F4B6695105Q37438344-BD283DD4-0C75-4F5D-B36D-05D5293F56B1Q37467208-CEAC4BA3-E668-4896-84E1-07BEC210D242Q37626062-A2811728-2374-4350-A116-769945A42D32
P2860
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Molecular profiling and predic ...... east cancer related therapies.
@en
Molecular profiling and predic ...... east cancer related therapies.
@nl
type
label
Molecular profiling and predic ...... east cancer related therapies.
@en
Molecular profiling and predic ...... east cancer related therapies.
@nl
prefLabel
Molecular profiling and predic ...... east cancer related therapies.
@en
Molecular profiling and predic ...... east cancer related therapies.
@nl
P2093
P1476
Molecular profiling and predic ...... east cancer related therapies.
@en
P2093
Mitra Tewes
Rainer Kimmig
Sabine Kasimir-Bauer
Siegfried Hauch
Siemke Mueller
P2888
P304
P356
10.1007/S10549-008-0143-X
P407
P577
2008-08-05T00:00:00Z